Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))

In the original publication, affiliation p was listed as Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. The authors would like it to be noted that the institution for this affiliation has IRCCS accreditation and the correct institution name is correctly listed above. Conflicts of interest: The authors have nothing to disclose.